BRIEF-U.S. FDA says expanded approved use of Subcutaneous Actemra to treat adults with Giant Cell Arteritis

* U.S. FDA says expanded the approved use of Subcutaneous Actemra (Tocilizumab) to treat adults with Giant Cell Arteritis

by reutersCOMPANYNEWS via Endless Supplies .Biz - News